Impact of Dupilumab on Sinonasal Symptoms and Outcomes in Severe Chronic Rhinosinusitis With Nasal Polyps
Otolaryngology–Head and Neck Surgery · 2024
DOI: 10.1002/ohn.627 ↗At a glance
Randomisierte kontrollierte Studie in Otolaryngology–Head and Neck Surgery, 2024. Written by Claire Hopkins and 14 co-authors. Institution: Department of Otorhinolaryngology, King's College London, London, UK. Major MEDLINE topics: Antibodies, Monoclonal, Humanized, Nasal Polyps, Rhinitis, Rhinosinusitis. Cited 22 times so far (Crossref); 22 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Objectives
To assess the severity of the top 5 22‐item Sino‐Nasal Outcome Test (SNOT‐22) items ranked most important by patients with chronic rhinosinusitis with nasal polyps (CRSwNP), the effect of dupilumab on these items, and their association with objective disease measures. Study Design Post hoc analysis of the SINUS‐24 (NCT02912468) and SINUS‐52 (NCT02898454) clinical trials.
Setting
Multinational, multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group studies.
Methods
Patients ranked the SNOT‐22 items most affecting their health at baseline. Item symptom severity (0‐5 scale) was assessed at baseline, Week 24 (W24), and Week 52 (W52). Changes in nasal polyps score (NPS) and Lund–Mackay (LMK) scores were assessed in patients with/without SNOT‐22 items improvements of at least 1 severity group point at W24 and W52.
Results
The SNOT‐22 items ranked most important at baseline were “decreased sense of smell/taste” (87% of patients), followed by “nasal blockage” (82%), “postnasal discharge” (40%), “thick nasal discharge” (37%), and “wake up at night” (26%); 82%, 61%, 32%, 40%, and 26% of patients reported severe symptoms (score 4 or 5) for these items, respectively. Dupilumab improved score severity for all top 5 items versus placebo at W24 and W52. Improvements in NPS and LMK scores were numerically greater in patients with improvements in the SNOT‐22 top 5 items.
Conclusion
Loss of smell/taste was ranked as the most important symptom by patients with CRSwNP. Dupilumab reduced the severity of the top 5 most important SNOT‐22 items versus placebo, in parallel with improvements in objective disease measures. Clinical Trial Registration SINUS‐24 and SINUS‐52 clinical trials were registered with ClinicalTrials.gov , identifiers NCT02912468 and NCT02898454, respectively.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Otorhinolaryngology, King's College London, London, UK.
- Hospital Clínic Barcelona, FRCB-IDIBAPS, Universitat de Barcelona, CIBERES, Barcelona, Catalonia, Spain.
- Global Medical Affairs, Sanofi, Chilly-Mazarin, France.
- Harvard Medical School, Brigham and Women's Hospital, Division of Otolaryngology-Head & Neck Surgery, Boston, Massachusetts, USA.
- Department of Otorhinolaryngology, Düsseldorf University Hospital (UKD), Düsseldorf, Germany.
- Department of Otorhinolaryngology-Head and Neck Surgery, University Hospitals Leuven, Leuven, Belgium.
ORCID profiles: Claire Hopkins, Joaquim Mullol, Asif H Khan, Stella E Lee, Martin Wagenmann, Peter Hellings, Wytske Fokkens, Jérôme Msihid, Radhika Nair, Siddhesh Kamat, Scott Nash, Amr Radwan, Juby A Jacob-Nara
Cite
APA
Hopkins, C., Mullol, J., Khan, A. H., Lee, S. E., Wagenmann, M., Hellings, P., Fokkens, W., Msihid, J., Nair, R., Kamat, S., Nash, S., Radwan, A., Jacob-Nara, J. A., Deniz, Y., & Rowe, P. J. (2024). Impact of Dupilumab on Sinonasal Symptoms and Outcomes in Severe Chronic Rhinosinusitis With Nasal Polyps. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.627
Vancouver
Hopkins C, Mullol J, Khan AH, Lee SE, Wagenmann M, Hellings P, et al. Impact of Dupilumab on Sinonasal Symptoms and Outcomes in Severe Chronic Rhinosinusitis With Nasal Polyps. Otolaryngology–Head and Neck Surgery. 2024. doi:10.1002/ohn.627
BibTeX
@article{Hopkins2024,
author = {Hopkins, Claire and Mullol, Joaquim and Khan, Asif H and Lee, Stella E and Wagenmann, Martin and Hellings, Peter and Fokkens, Wytske and Msihid, Jérôme and Nair, Radhika and Kamat, Siddhesh and Nash, Scott and Radwan, Amr and Jacob-Nara, Juby A and Deniz, Yamo and Rowe, Paul J},
title = {Impact of Dupilumab on Sinonasal Symptoms and Outcomes in Severe Chronic Rhinosinusitis With Nasal Polyps},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2024},
doi = {10.1002/ohn.627}
}
EUVIMED